Ingredient
Palm Kernelamide Dea
Palm Kernelamide Dea is flagged for pregnancy, breastfeeding, postpartum, trying to conceive, PCOS and general use. The concern behind the strongest flag is absorbed into the body and carcinogen concern.
- Palm Kernel Acid Diethanolamide
- Coconut Oil Acid Diethanolamide
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Caution Advised
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Palm Kernelamide Dea and pregnancy
Caution Advised
- Absorbed into the body
- Carcinogen concern
Palm kernelamide DEA is a surfactant and emulsifier derived from palm oil and diethanolamine (DEA). DEA compounds have raised concerns due to potential contamination with nitrosamines, which are known carcinogens, and the ability of DEA itself to be absorbed through the skin. While no specific pregnancy studies exist for this ingredient, the general concerns about DEA derivatives during pregnancy stem from potential fetal exposure to both DEA and nitrosamine contaminants. Animal studies have shown that DEA can interfere with choline uptake, which is crucial for fetal brain development. The FDA has expressed concern about DEA absorption, particularly in products that remain on skin or are used frequently. Many obstetricians and dermatologists recommend that pregnant women avoid DEA-containing products when possible, particularly leave-on formulations. The EU's more restrictive approach to DEA ingredients reflects the precautionary principle often applied during pregnancy. Safer alternatives exist for the same functions.
Palm Kernelamide Dea and breastfeeding
Caution Advised
- Absorbed into the body
DEA compounds like palm kernelamide DEA can be absorbed through the skin during repeated use. While specific data on transfer to breast milk is limited, the general concern about DEA's systemic effects extends to breastfeeding periods. The potential for nitrosamine contamination and DEA's ability to affect choline metabolism raise theoretical concerns for breastfeeding mothers. While cosmetic use involves lower exposure than seen in animal studies, the precautionary approach favored during breastfeeding suggests choosing alternative surfactants when available. Dermatologists generally recommend that breastfeeding women minimize exposure to DEA derivatives, particularly in products used daily or left on the skin. The concern is not acute toxicity but rather cumulative exposure to potentially problematic compounds. Many modern formulations have moved away from DEA ingredients in favor of safer alternatives.
Palm Kernelamide Dea and postpartum
Caution Advised
- Carcinogen concern
- Irritant
For postpartum women not breastfeeding, the concerns about palm kernelamide DEA are the same as for the general population: potential nitrosamine contamination and the effects of DEA absorption. There are no specific postpartum considerations beyond general skin sensitivity. Given the availability of safer surfactant alternatives and the increasing regulatory restrictions on DEA compounds, choosing products without DEA derivatives remains advisable even when pregnancy and breastfeeding concerns don't apply.
Palm Kernelamide Dea and trying to conceive
Caution Advised
- Absorbed into the body
While palm kernelamide DEA has no documented direct effects on fertility, the concerns about DEA compounds include potential interference with choline metabolism, which is important for reproductive health. Women trying to conceive often choose to follow pregnancy guidelines preemptively. The precautionary approach suggests minimizing exposure to DEA derivatives when trying to conceive, particularly given that many women don't know they're pregnant during early weeks when fetal development is most vulnerable. Alternative surfactants are readily available and equally effective.
Palm Kernelamide Dea and PCOS
Caution Advised
Palm kernelamide DEA has no direct effects on hormones, androgens, or insulin sensitivity relevant to PCOS. However, the general health concerns about DEA compounds apply to all users, including women with PCOS. Women with PCOS often use cleansing products frequently to manage oily skin and acne. This increased use could potentially lead to greater DEA exposure, making the choice of surfactants more relevant. The concerns about DEA are not PCOS-specific but apply to long-term, repeated use. There are no contraindications with PCOS medications, but choosing cleansers with alternative surfactants like betaines or glucosides may be preferable given the general concerns about DEA compounds and the availability of safer options.
Palm Kernelamide Dea and general use
Caution Advised
- Carcinogen concern
- Irritant
Palm kernelamide DEA is a surfactant and foam booster used in cleansers and shampoos. It belongs to the DEA (diethanolamine) family of ingredients, which have come under increased scrutiny due to concerns about nitrosamine contamination and potential health effects from DEA absorption. The FDA has expressed concern about DEA compounds, noting that DEA can react with other ingredients to form nitrosamines, which are known carcinogens. Studies have also shown that DEA can be absorbed through the skin and may interfere with choline metabolism. The International Agency for Research on Cancer (IARC) has classified DEA as possibly carcinogenic to humans based on animal studies. The EU has restricted DEA compounds in cosmetics, requiring manufacturers to ensure products do not form nitrosamines and limiting use in leave-on products. While not banned in the US, many manufacturers are reformulating to remove DEA ingredients due to consumer concerns and regulatory trends. Safer alternatives like cocamidopropyl betaine and plant-derived glucosides are widely available.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Palm Kernelamide Dea, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store